Nkarta (NKTX)
2.51
-0.26 (9.39%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13D/A Nkarta, Inc. Filed by: New Enterprise Associates 15, L.P.
May 19, 2026 4:04 PM - SEC Filing
Nkarta, Inc. (NKTX) Misses Q1 EPS by 2c
May 12, 2026 5:14 PM - StreetInsider
Form 10-Q Nkarta, Inc. For: Mar 31
May 12, 2026 4:10 PM - SEC Filing
Form 8-K Nkarta, Inc. For: May 12
May 12, 2026 4:05 PM - SEC Filing
Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights
May 12, 2026 4:01 PM - StreetInsider
Form DEFA14A Nkarta, Inc.
April 23, 2026 7:06 PM - SEC Filing
Form ARS Nkarta, Inc. For: Dec 31
April 23, 2026 7:06 PM - SEC Filing
Form DEF 14A Nkarta, Inc. For: Jun 10
April 23, 2026 7:06 PM - SEC Filing
Nkarta gets FDA approval for outpatient dosing of autoimmune therapy
April 15, 2026 4:01 PM - StreetInsider
Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers
April 15, 2026 4:01 PM - StreetInsider
Nkarta to Participate in Needham Virtual Healthcare Conference
April 9, 2026 7:00 AM - StreetInsider
Form EFFECT Nkarta, Inc.
April 6, 2026 6:01 AM - SEC Filing
Form 424B5 Nkarta, Inc.
April 3, 2026 5:29 PM - SEC Filing
Nkarta Inc. (NKTX) PT Lowered to $12 at Mizuho
March 30, 2026 8:56 AM - StreetInsider
Nkarta Inc. (NKTX) PT Raised to $11 at Needham
March 26, 2026 7:34 AM - StreetInsider
Nkarta (NKTX) Reiterated at Buy by Stifel; Estimates Largely Unchanged
March 26, 2026 7:19 AM - StreetInsider
Form 8-K Nkarta, Inc. For: Mar 25
March 26, 2026 6:01 AM - SEC Filing
Form S-3 Nkarta, Inc.
March 25, 2026 5:23 PM - SEC Filing
Nkarta, Inc. (NKTX) Misses Q4 EPS by 6c
March 25, 2026 5:04 PM - StreetInsider
Form 10-K Nkarta, Inc. For: Dec 31
March 25, 2026 4:09 PM - SEC Filing
Form 8-K Nkarta, Inc. For: Mar 25
March 25, 2026 4:04 PM - SEC Filing
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights
March 25, 2026 4:01 PM - StreetInsider
Full Article List
